Design Therapeutics, Inc.DSGNNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
10.47%
↑ 153% above average
Average (22q)
-19.84%
Historical baseline
Range
High:19.66%
Low:-134.83%
Volatility
-778.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 10.47% |
| Q2 2025 | -5.64% |
| Q1 2025 | -22.31% |
| Q4 2024 | -2.76% |
| Q3 2024 | -8.00% |
| Q2 2024 | -4.47% |
| Q1 2024 | 4.77% |
| Q4 2023 | 19.66% |
| Q3 2023 | 16.70% |
| Q2 2023 | -4.36% |
| Q1 2023 | -11.65% |
| Q4 2022 | -1.04% |
| Q3 2022 | -22.72% |
| Q2 2022 | -16.97% |
| Q1 2022 | -20.16% |
| Q4 2021 | 1.85% |
| Q3 2021 | -47.48% |
| Q2 2021 | -35.33% |
| Q1 2021 | -47.11% |
| Q4 2020 | -62.02% |
| Q3 2020 | -62.88% |
| Q2 2020 | -134.83% |
| Q1 2020 | 0.00% |